Who Buys Ezetimibe from India — 466 Importers Behind a $514.5M Market
India's ezetimibe import market is served by 466 active buyers who collectively imported $514.5M across 5,033 shipments. DAIICHI SANKYO EUROPE GMBH (GERMANY) leads with a 38.9% market share, followed by PCI PHARMA SERVICES and ASCEND LABORATORIES LLC. The top 5 buyers together control 84.1% of total import value, reflecting a concentrated buyer landscape.
Top Ezetimibe Importers — Ranked by Import Value
DAIICHI SANKYO EUROPE GMBH (GERMANY) is the leading ezetimibe importer from India, holding a 38.9% share of the $514.5M market across 5,033 shipments from 466 buyers. The top 5 buyers — DAIICHI SANKYO EUROPE GMBH (GERMANY), PCI PHARMA SERVICES (UNITED STATES), ASCEND LABORATORIES LLC (UNITED STATES), BGP PRODUCTS GMBH (NETHERLANDS), NEXTPHARMA LOGISTIC GMBH (GERMANY) — collectively control 84.1% of total import value.
Top Ezetimibe Buyers & Importers
Ranked by import value · 466 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | DAIICHI SANKYO EUROPE GMBHGERMANY PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS [10X10T PER PACK] | $200.3M | 5 | 38.9% |
| 2 | PCI PHARMA SERVICESUNITED STATES EZETIMIBE TABLETS USP 10MG [12009 PACK X 500'S] (EZETIMIBE TABLETS USP 10MG [7416 PACK X 500'S] (EZETIMIBE TABLET | $109.0M | 5 | 21.2% |
| 3 | ASCEND LABORATORIES LLCUNITED STATES EZETIMIBE TABLETS USP 10MG [12009 PACK X 500'S] (EZETIMIBE TABLETS USP 10MG [7416 PACK X 500'S] (PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS [10X10T PER PACK] | $99.8M | 5 | 19.4% |
| 4 | BGP PRODUCTS GMBHNETHERLANDS ROSUVASTATIN 10MG AND EZETIMIBE 10MG TABROSUVASTATIN 20MG AND EZETIMIBE 10MG TABPHARMA DRUGS & MEDI EZETIMIBE 10MG 7X14T | $16.4M | 5 | 3.2% |
| 5 | NEXTPHARMA LOGISTIC GMBHGERMANY PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS [10X10T PER PACK] | $7.2M | 5 | 1.4% |
| 6 | ASCEND LABORATORIES,LLCUNITED STATES EZETIMIBE TABLETS USP 10MG [12009 PACK X 500'S] (EZETIMIBE TABLETS USP 10MG [7416 PACK X 500'S] (PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS [10X10T PER PACK] | $6.7M | 5 | 1.3% |
| 7 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM EZETIMIBE MYLAN 10 MG TAB 100BTEZETIMIBE TABLETS 10MG ( ETIBAX TAB 10MG | $3.4M | 5 | 0.7% |
| 8 | SENTRY BIOPHARMA SERVICES, INCUNITED STATES | $3.4M | 5 | 0.7% |
| 9 | ACCORD HEALTHCARE PTE LTDSINGAPORE MEZIBE TAB 10MG PACK:MEZIBE TAB 10MG 3X10S SAFR PACK:SP 10S STRIP BATCH:DFF8399AEZETIMIBE TAB.10MG-02X14S, | $2.8M | 5 | 0.5% |
| 10 | VIATRIS BV C/O LIVLINA,BELGIUM EZETIMIBE MYLAN 10 MG TAB 100BTROSUVASTATIN 10MG AND EZETIMIBE 10MG TABROSUVASTATIN 20MG AND EZETIMIBE 10MG TAB | $2.8M | 5 | 0.5% |
| 11 | MICRO LABS GMBHGERMANY PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS [10X10T PER PACK]EZETIMIBE MYLAN 10 MG TAB 100BTROSUVASTATIN 10MG AND EZETIMIBE 10MG TAB | $2.6M | 5 | 0.5% |
| 12 | LEK D.DSLOVENIA | $1.7M | 5 | 0.3% |
| 13 | ESPERION THERAPEUTICS INC.UNITED STATES | $1.6M | 5 | 0.3% |
| 14 | CSP MYLAN SAS AT CSP LABO 274FRANCE HARMLESS MEDICINES, EZETIMIBE/SIMVASTATIEZETIMIBE MYLAN 10MG 90BL TAB PACK 58377EZETIMIBE MYLAN 10 MG 90BL TAB (113205 P | $1.6M | 5 | 0.3% |
| 15 | MSK PHARMALOGISTIC GMBHGERMANY PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS [10X10T PER PACK] | $1.4M | 5 | 0.3% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Ezetimibe — and from which countries?
Flow of Ezetimibe exports from India: each country's share and the named importers behind the numbers
Ezetimibe — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $231.1M through 313 shipments. This represents a market share of 44.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• PCI PHARMA SERVICES - $109.0M (47.2% of country's total business)
• ASCEND LABORATORIES LLC - $99.8M (43.2% of country's total business)
• ASCEND LABORATORIES,LLC - $6.7M (2.9% of country's total business)
• SENTRY BIOPHARMA SERVICES, INC - $3.4M (1.5% of country's total business)
• ESPERION THERAPEUTICS INC. - $1.6M (0.7% of country's total business)
• Rest of United States's importers - $10.6M (4.6% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $738.4K, indicating premium pricing strategy compared to the market average of $102.2K.
United States is a key market for Ezetimibe imports, representing 44.9% of total trade value.
2Germany
Germany emerges as the second largest importing country, achieving a total trade value of $213.0M through 272 shipments. This represents a market share of 41.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• DAIICHI SANKYO EUROPE GMBH - $200.3M (94.0% of country's total business)
• NEXTPHARMA LOGISTIC GMBH - $7.2M (3.4% of country's total business)
• MICRO LABS GMBH - $2.6M (1.2% of country's total business)
• MSK PHARMALOGISTIC GMBH - $1.4M (0.7% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $783.0K, indicating premium pricing strategy compared to the market average of $102.2K.
Germany is a key market for Ezetimibe imports, representing 41.4% of total trade value.
3Netherlands
Netherlands emerges as the third largest importing country, achieving a total trade value of $20.3M through 566 shipments. This represents a market share of 4.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BGP PRODUCTS GMBH - $16.4M (80.4% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $35.9K, indicating competitive pricing strategy compared to the market average of $102.2K.
Netherlands is a key market for Ezetimibe imports, representing 4.0% of total trade value.
4Australia
Australia emerges as the fourth largest importing country, achieving a total trade value of $6.8M through 25 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• APOTEX PTY LIMITED - $1.3M (19.6% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $271.9K, indicating premium pricing strategy compared to the market average of $102.2K.
Australia is a key market for Ezetimibe imports, representing 1.3% of total trade value.
5Belgium
Belgium emerges as the fifth largest importing country, achieving a total trade value of $6.8M through 104 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $3.4M (49.9% of country's total business)
• VIATRIS BV C/O LIVLINA, - $2.8M (40.6% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $65.3K, indicating competitive pricing strategy compared to the market average of $102.2K.
Belgium is a key market for Ezetimibe imports, representing 1.3% of total trade value.
Buyer Segment Analysis
TransData Nexus Ezetimibe buyer market intelligence
1Buyer Segment Analysis
Ezetimibe imports from India are primarily distributed among the following buyer segments:
1. Pharmaceutical Companies and Contract Manufacturers: These entities procure Ezetimibe as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Notable buyers in this category include DAIICHI SANKYO EUROPE GMBH (Germany, $200.28M) and BGP PRODUCTS GMBH (Netherlands, $16.35M). Their purchasing behavior is characterized by large-volume orders to meet production demands, often engaging in long-term supply agreements to ensure consistent API availability.
2. Distributors and Logistics Providers: Companies such as PCI PHARMA SERVICES (United States, $109.00M) and NEXTPHARMA LOGISTIC GMBH (Germany, $7.21M) fall into this segment. They specialize in the distribution and logistics of pharmaceutical products, facilitating the movement of Ezetimibe from manufacturers to various markets. Their order patterns are influenced by market demand and inventory management strategies, often involving multiple shipments to different regions.
3. Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $3.39M) and VIATRIS BV C/O LIVLINA (Belgium, $2.76M) operate as intermediaries, importing Ezetimibe for the purpose of re-exporting to other countries. Their buying behavior is driven by global market demands and trade agreements, leading to variable order sizes and frequencies.
Understanding these segments is crucial for tailoring marketing strategies and supply chain operations to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Ezetimibe buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Ezetimibe from India, the import regulations are as follows:
1. United States:
2. Germany:
3. Netherlands:
4. Australia:
5. Belgium:
Compliance with these regulations is essential for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Ezetimibe buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Ezetimibe in importing countries is influenced by several factors:
1. Prevalence of Hypercholesterolemia: Ezetimibe is prescribed to lower cholesterol levels, a common condition globally. The increasing prevalence of hypercholesterolemia, partly due to lifestyle changes, drives the demand for cholesterol-lowering medications.
2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding UHC schemes, increasing access to essential medicines. For instance, the inclusion of Ezetimibe in national formularies and reimbursement lists enhances its accessibility and affordability, thereby boosting demand.
3. WHO Essential Medicines List (EML) Procurement: While Ezetimibe is not currently listed on the WHO EML, its inclusion in national essential medicines lists can influence procurement decisions, especially in low- and middle-income countries aiming to improve access to essential treatments.
4. Tender-Based Purchasing: Public sector procurement often utilizes tendering processes to acquire medicines cost-effectively. Competitive tendering can lead to increased demand for Ezetimibe, as suppliers strive to meet the requirements of large-scale public health programs.
With 466 buyers across 85 countries, the global market for Ezetimibe presents significant opportunities. Understanding the interplay between disease prevalence, healthcare policies, and procurement mechanisms is vital for stakeholders aiming to optimize their market strategies.
Common Questions — Ezetimibe Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ezetimibe buyer importing from India?
Based on import volume and value, DAIICHI SANKYO EUROPE GMBH (GERMANY) leads with $200.3M in imports and a 38.9% market share — the highest of any single ezetimibe importer. PCI PHARMA SERVICES (UNITED STATES) and ASCEND LABORATORIES LLC (UNITED STATES) are the next largest buyers.
QHow many companies buy ezetimibe from India?
There are 466 active ezetimibe buyers importing from India, with a combined market of $514.5M across 5,033 shipments to 85 countries. The top 5 buyers hold 84.1% of total import value, while the remaining 461 buyers handle the other 15.9%.
QWhich countries import the most ezetimibe from India?
The top importing countries for ezetimibe from India are United States (44.9%), Germany (41.4%), Netherlands (4.0%), Australia (1.3%), Belgium (1.3%). These markets represent the largest demand centres for Indian pharmaceutical exports of ezetimibe, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for ezetimibe from India?
The average import transaction value for ezetimibe from India is $102.2K, with an average unit price of $20.96 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Ezetimibe buyer market intelligence
1Buyer Segment Analysis
Ezetimibe imports from India are primarily distributed among the following buyer segments:
1. Pharmaceutical Companies and Contract Manufacturers: These entities procure Ezetimibe as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Notable buyers in this category include DAIICHI SANKYO EUROPE GMBH (Germany, $200.28M) and BGP PRODUCTS GMBH (Netherlands, $16.35M). Their purchasing behavior is characterized by large-volume orders to meet production demands, often engaging in long-term supply agreements to ensure consistent API availability.
2. Distributors and Logistics Providers: Companies such as PCI PHARMA SERVICES (United States, $109.00M) and NEXTPHARMA LOGISTIC GMBH (Germany, $7.21M) fall into this segment. They specialize in the distribution and logistics of pharmaceutical products, facilitating the movement of Ezetimibe from manufacturers to various markets. Their order patterns are influenced by market demand and inventory management strategies, often involving multiple shipments to different regions.
3. Re-exporters: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $3.39M) and VIATRIS BV C/O LIVLINA (Belgium, $2.76M) operate as intermediaries, importing Ezetimibe for the purpose of re-exporting to other countries. Their buying behavior is driven by global market demands and trade agreements, leading to variable order sizes and frequencies.
Understanding these segments is crucial for tailoring marketing strategies and supply chain operations to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Ezetimibe buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Ezetimibe from India, the import regulations are as follows:
1. United States:
2. Germany:
3. Netherlands:
4. Australia:
5. Belgium:
Compliance with these regulations is essential for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Ezetimibe buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Ezetimibe in importing countries is influenced by several factors:
1. Prevalence of Hypercholesterolemia: Ezetimibe is prescribed to lower cholesterol levels, a common condition globally. The increasing prevalence of hypercholesterolemia, partly due to lifestyle changes, drives the demand for cholesterol-lowering medications.
2. Government Healthcare Programs and Universal Health Coverage (UHC): Many countries are expanding UHC schemes, increasing access to essential medicines. For instance, the inclusion of Ezetimibe in national formularies and reimbursement lists enhances its accessibility and affordability, thereby boosting demand.
3. WHO Essential Medicines List (EML) Procurement: While Ezetimibe is not currently listed on the WHO EML, its inclusion in national essential medicines lists can influence procurement decisions, especially in low- and middle-income countries aiming to improve access to essential treatments.
4. Tender-Based Purchasing: Public sector procurement often utilizes tendering processes to acquire medicines cost-effectively. Competitive tendering can lead to increased demand for Ezetimibe, as suppliers strive to meet the requirements of large-scale public health programs.
With 466 buyers across 85 countries, the global market for Ezetimibe presents significant opportunities. Understanding the interplay between disease prevalence, healthcare policies, and procurement mechanisms is vital for stakeholders aiming to optimize their market strategies.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 466 global importers of Ezetimibe identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 5,033 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 85 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,033 Verified Shipments
466 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists